Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
One week oral flurazepam (FZP) administration in rats results in anticonvulsant tolerance in vivo, tolerance measured in vitro in hippocampal CA1 pyramidal cells, and regulation of hippocampal gamma-aminobutyric acid(A)-receptor subunit protein expression. A single injection (4 or 20 mg/kg i.p) of the benzodiazepine antagonist flumazenil (FLM) was given 1 day after FZP treatment, and tolerance and subunit protein expression were evaluated 1 day later. In vivo tolerance was measured by a reduced ability of the alpha(1)-subunit-selective agonist zolpidem to suppress pentylenetetrazole-induced seizures. This tolerance was reversed by 20 but not 4 mg/kg FLM. In in vitro hippocampal slices, there was tolerance to the effect of zolpidem to prolong the decay of pyramidal cell miniature inhibitory postsynaptic currents, which was reversed by FLM (4 mg/kg) pretreatment. A reduction in miniature inhibitory postsynaptic current amplitude ( approximately 50%) was also restored by FLM injection. [(3)H]Zolpidem binding measured 0, 2, and 7 days after FZP treatment was significantly decreased in the hippocampus and cortex at 0 days but not thereafter. Changes in alpha(1)- and beta(3)-subunit protein expression were examined via quantitative immunohistochemical techniques. alpha(1)-Subunit protein levels were down-regulated in the CA1 stratum oriens and beta subunit levels were up-regulated in the stratum oriens and stratum radiatum of the CA3 region. Chronic FZP effects on alpha(1)- and beta(3)-subunit protein levels were also reversed by prior FLM injection. FLM's effect on both functional and structural correlates of benzodiazepine tolerance suggests that each of these measures plays an interdependent role in mediating benzodiazepine tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
Which GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity
Gallager, D. W., Lakoski, J. M., Gonsalves, S. F., & Rauch, S. L. (1984) · Nature · doi:10.1038/308074a0 · Cited by 280
Primus, R. J., Yu, J., Xu, J., Hartnett, C., Meyyappan, M., Kostas, C., Ramabhadran, T. V., & Gallager, D. W. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12410-5 · Cited by 60 · cited 1×
“Allosteric uncoupling in a baculovirus recombinant expression system was dependent on ligand efficacy, was subunit specific (e.g., zolpidem exposure decreased coupling in ␣ 1  2 ␥ 2 -but not ␣ 5  2 ␥ 2 -recombinant receptors), and was reversed by a brief exposure to FLM (Primus et al., 1996).”
Klein, R. L., Mascia, M. P., Harkness, P. C., Hadingham, K. L., Whiting, P. J., & Harris, R. A. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10707-6 · Cited by 40
Itier, V, Granger, P., Perrault, G., Depoortere, H., Scatton, B., & Avenet, P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21265-4 · Cited by 16
Cited by
Fritschy, J.-M., & Brünig, I. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00037-8 · Cited by 324
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Ali, N. J., & Olsen, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00664.x · Cited by 67
Lilly, S. M., Zeng, X. J., & Tietz, E. I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01746.x · Cited by 21
Self-citation
Metadata
- Authors
- Tietz, E. I., Zeng, X. J., Chen, S., Lilly, S. M., Rosenberg, H. C., & Kometiani, P.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 291
- Issue
- 3
- Pages
- 932-942
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2295927910
- Cited by
- 40
- References
- 6
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance. https://app.cochat.ai/papers/10.1016/s0022-3565(24)35193-6
- The paper
- Tietz, E. I., Zeng, X. J., Chen, S., Lilly, S. M., Rosenberg, H. C., & Kometiani, P. (1999). Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)35193-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.